These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 37550092

  • 1. Therapeutic plasma exchange in alloimmune platelet refractoriness.
    Raza S, Patriquin CJ, Yee K, Gupta A, Anani W, Wong J, Ellison C, Lieberman L, Pendergrast J, Cserti-Gazdewich C.
    Transfus Apher Sci; 2023 Dec; 62(6):103782. PubMed ID: 37550092
    [Abstract] [Full Text] [Related]

  • 2. Platelet transfusion refractoriness due to HLA alloimmunization: Evolving paradigms in mechanisms and management.
    Panch SR, Guo L, Vassallo R.
    Blood Rev; 2023 Nov; 62():101135. PubMed ID: 37805287
    [Abstract] [Full Text] [Related]

  • 3. Human Leukocyte Antigen Alloimmunization and Alloimmune Platelet Refractoriness.
    Saris A, Pavenski K.
    Transfus Med Rev; 2020 Oct; 34(4):250-257. PubMed ID: 33127210
    [Abstract] [Full Text] [Related]

  • 4. Rituximab, plasma exchange and intravenous immunoglobulins as a new treatment strategy for severe HLA alloimmune platelet refractoriness.
    Cid J, Magnano L, Acosta M, Alba C, Esteve J, Lozano M.
    Platelets; 2015 Oct; 26(2):190-4. PubMed ID: 24867634
    [Abstract] [Full Text] [Related]

  • 5. ABSOLUTE PLATELET REFRACTORINESS ASSOCIATED WITH HLA ANTIBODIES: A CASE REPORT.
    Vora M, Ong M, Al-Delfi F, Dela Cruz N, Veillon D, Cotelingam J.
    J La State Med Soc; 2016 Oct; 168(1):8-11. PubMed ID: 26986860
    [Abstract] [Full Text] [Related]

  • 6. Anti-HLA Class I alloantibodies in platelet transfusion refractoriness: From mechanisms and determinants to therapeutic prospects.
    Couvidou A, Rojas-Jiménez G, Dupuis A, Maître B.
    Front Immunol; 2023 Oct; 14():1125367. PubMed ID: 36845153
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions.
    Trial to Reduce Alloimmunization to Platelets Study Group.
    N Engl J Med; 1997 Dec 25; 337(26):1861-9. PubMed ID: 9417523
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Successful treatment of platelet transfusion refractoriness: the use of platelet transfusions matched for both human leucocyte antigens (HLA) and human platelet alloantigens (HPA) in alloimmunized patients with leukaemia.
    Kekomäki S, Volin L, Koistinen P, Koivunen E, Koskimies S, Ruutu T, Timonen T, Kekomäki R.
    Eur J Haematol; 1998 Feb 25; 60(2):112-8. PubMed ID: 9508352
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Severe neonatal alloimmune thrombocytopenia due to anti-HPA-3a.
    Boehlen F, Kaplan C, de Moerloose P.
    Vox Sang; 1998 Feb 25; 74(3):201-4. PubMed ID: 9595650
    [Abstract] [Full Text] [Related]

  • 13. Human Leukocyte Antigen Class I Antibodies and Response to Platelet Transfusion in Patients Undergoing Liver Transplantation.
    Wong M, Narra R, Selim M, Zimmerman MA, Kim J, Padmanabhan A, Hong JC.
    J Surg Res; 2020 Nov 25; 255():99-105. PubMed ID: 32543385
    [Abstract] [Full Text] [Related]

  • 14. Recognition and management of antibodies to human platelet antigens in platelet transfusion-refractory patients.
    Vassallo RR.
    Immunohematology; 2009 Nov 25; 25(3):119-24. PubMed ID: 20406018
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Managing of platelet transfusion refractoriness of haematological malignancies. Experience IPC-EFSAM].
    Dettori I, Ladaique P.
    Transfus Clin Biol; 2014 Nov 25; 21(4-5):207-9. PubMed ID: 25267204
    [Abstract] [Full Text] [Related]

  • 18. [Platelet transfusion refractoriness and effective management of platelet alloimmunization].
    Amemiya Y.
    Nihon Rinsho; 1997 Sep 25; 55(9):2392-8. PubMed ID: 9301306
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.